Prozac's brain effects under the microscope in healthy youth
NCT ID NCT07456501
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how a week of Prozac (fluoxetine) changes decision-making and social thinking in 80 healthy people aged 18-24. Participants take either Prozac or a placebo, then complete tasks on emotion recognition, reward learning, and social exclusion. The goal is to better understand how antidepressants work in young brains, which could improve treatment for depression.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
fluoxetine (Prozac)
What this could lead to
If successful, this study could help doctors understand which young people might benefit most from antidepressants like Prozac.
What could go wrong
This is an early-stage study in healthy volunteers, not patients. It only lasts 7 days, so long-term effects or real-world benefits are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION IN ADOLESCENCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Oxford Department of Psychiatry
Oxford, OX3 7JX, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact